Mutations simultaneously affecting both BRCA1 and BRCA2 mainly occurred in head/neck squamous cell carcinoma (18.8%) and cutaneous melanoma (12.5%). This evidence concerns the gene BRCA2 and head and neck squamous cell carcinoma.